Standout Papers

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe al... 2001 2026 2009 2017 956
  1. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma (2001)
    William W. Busse, Jonathan Corren et al. Journal of Allergy and Clinical Immunology
  2. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics (2001)
    M. Solèr, Jonathan Matz et al. European Respiratory Journal

Immediate Impact

6 from Science/Nature 76 standout
Sub-graph 1 of 20

Citing Papers

A natural experiment on the effect of herpes zoster vaccination on dementia
2025 StandoutNature
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
8 intermediate papers

Works of Niroo Gupta being referenced

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
2001 Standout
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
2001 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Niroo Gupta 2474 1430 1694 17 2.8k
Angel FowlerTaylor 2125 1207 1397 18 2.3k
Martin Blogg 2220 1337 1661 32 2.4k
H. Fox 1758 1002 1392 24 2.0k
Magnus Aurivillius 2417 531 2168 42 3.1k
J. Thirlwell 1697 1015 1239 16 1.9k
E Ädelroth 2399 823 1820 40 3.3k
Stephanie Sproule 2381 577 1785 8 2.6k
Bobby Q. Lanier 2019 2168 912 31 3.3k
Steven F. Weinstein 2270 995 1533 44 2.6k
S. Hedgecock 1548 1055 1064 15 1.8k

All Works

Loading papers...

Rankless by CCL
2026